TSHA Annual Total Long Term Liabilities
$61.04 M
-$1.50 M-2.40%
31 December 2023
Summary:
As of January 23, 2025, TSHA annual total long term liabilities is $61.04 million, with the most recent change of -$1.50 million (-2.40%) on December 31, 2023. During the last 3 years, it has risen by +$60.59 million (+13464.00%). TSHA annual total long term liabilities is now -8.66% below its all-time high of $66.83 million, reached on December 31, 2021.TSHA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Quarterly Long Term Liabilities
$62.09 M
+$4.74 M+8.26%
30 September 2024
Summary:
As of January 23, 2025, TSHA quarterly total long term liabilities is $62.09 million, with the most recent change of +$4.74 million (+8.26%) on September 30, 2024. Over the past year, it has dropped by -$2.35 million (-3.64%). TSHA quarterly long term liabilities is now -8.72% below its all-time high of $68.02 million, reached on June 30, 2023.TSHA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.4% | -3.6% |
3 y3 years | +10000.0% | +8.1% |
5 y5 years | +100.0% | - |
TSHA Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.7% | at low | -8.7% | +8.3% |
5 y | 5-year | -8.7% | -8.7% | ||
alltime | all time | -8.7% | -8.7% |
Taysha Gene Therapies Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $62.09 M(+8.3%) |
June 2024 | - | $57.35 M(-5.2%) |
Mar 2024 | - | $60.51 M(-0.9%) |
Dec 2023 | $61.04 M(-2.4%) | $61.04 M(-5.3%) |
Sept 2023 | - | $64.43 M(-5.3%) |
June 2023 | - | $68.02 M(+9.5%) |
Mar 2023 | - | $62.09 M(-0.7%) |
Dec 2022 | $62.54 M | $62.54 M(-6.9%) |
Sept 2022 | - | $67.20 M(+0.8%) |
June 2022 | - | $66.67 M(+0.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $66.63 M(-0.3%) |
Dec 2021 | $66.83 M(>+9900.0%) | $66.83 M(+16.4%) |
Sept 2021 | - | $57.43 M(+112.9%) |
June 2021 | - | $26.97 M(+2600.1%) |
Mar 2021 | - | $999.00 K(+122.0%) |
Dec 2020 | $450.00 K(>+9900.0%) | - |
Dec 2020 | - | $450.00 K(>+9900.0%) |
Sept 2020 | - | $0.00(0.0%) |
June 2020 | - | $0.00 |
Dec 2019 | $0.00 | - |
FAQ
- What is Taysha Gene Therapies annual total long term liabilities?
- What is the all time high annual total long term liabilities for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual total long term liabilities year-on-year change?
- What is Taysha Gene Therapies quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly long term liabilities year-on-year change?
What is Taysha Gene Therapies annual total long term liabilities?
The current annual total long term liabilities of TSHA is $61.04 M
What is the all time high annual total long term liabilities for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual total long term liabilities is $66.83 M
What is Taysha Gene Therapies annual total long term liabilities year-on-year change?
Over the past year, TSHA annual total long term liabilities has changed by -$1.50 M (-2.40%)
What is Taysha Gene Therapies quarterly total long term liabilities?
The current quarterly long term liabilities of TSHA is $62.09 M
What is the all time high quarterly long term liabilities for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly total long term liabilities is $68.02 M
What is Taysha Gene Therapies quarterly long term liabilities year-on-year change?
Over the past year, TSHA quarterly total long term liabilities has changed by -$2.35 M (-3.64%)